eg technology is pleased to continue its ongoing partnership with Cambridge-based Ablatus Therapeutics, to help develop its novel minimally invasive treatment for soft tissue tumours. eg technology is pleased to continue its ongoing partnership with Cambridge-based Ablatus Therapeutics, to help develop its novel minimally invasive treatment for soft tissue tumours.
Ablatus is an England-based healthcare technology company that designs and distributes bimodal electric tissue ablation devices for the treatment of tumours and fibroids.